LATE GADOLINIUM ENHANCEMENT IN PATIENTS WITH MYOCARDITIS FROM IMMUNE CHECKPOINT INHIBITORS

Lili Zhang,Magid Awadalla,Syed S. Mahmood,John D. Groarke,Anju Nohria,Shiying Liu,Malek Z.O. Hassan,Justine V. Cohen,Maeve Jones OConnor,Sean Murphy,Lucie Heinzerling,Gagan Sahni,Carol Chen,Dipti Gupta,Javid Moslehi,Sarju Ganatra,Stéphane Ederhy,Franck Thuny,Alexander R. Lyon,Carlo G. Tocchetti,Muhammad A. Rizvi,Paaladinesh Thavendiranathan,Michael G. Fradley,Tomas G. Neilan

LATE GADOLINIUM ENHANCEMENT IN PATIENTS WITH MYOCARDITIS FROM IMMUNE CHECKPOINT INHIBITORS

2019

Myocarditis is a rare but potentially fatal complication of immune checkpoint inhibitors (ICI). Among broad populations, late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) is used for diagnosis and risk prediction in patients with myocarditis. There are no data on the use

Keywords:

Gadolinium
Immunology
Cardiology
Myocarditis
Diabetes mellitus
Medicine
Internal medicine
Immune checkpoint
Complication
in patient
late gadolinium enhancement
Cardiac magnetic resonance imaging
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations